Explain the key elements of FDA’s regulatory framework
Describe the policy issues surrounding the tobacco harm reduction debate
Identify the critical issues surrounding youth use of e-cigarettes
CME/CE is no longer available for this recorded activity.
Don't need CEUs but would like a certificate of attendance? Click here to generate your own certificate reflecting your contact hours earned on this webinar.
Disclosures
This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.
The following moderators and planning committee members have disclosed they have no financial interest/arrangement or affiliation with any commercial companies who have provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity:
Mitchell R. Zeller, JD, Jon Jovi Bodestyne, Christine Cheng, Brian Clark, Jennifer Matekuare, Jessica Safier, Catherine Saucedo, and Steven A. Schroeder, MD
- Center for Tobacco Products, FDA - https://www.fda.gov/tobaccoproducts/aboutctp/default.htm
- The Real Cost campaign - https://www.fda.gov/TobaccoProducts/PublicHealthEducation/PublicEducationCampaigns/TheRealCostCampaign/default.htm
- The Real Cost - campaign resources - https://www.fda.gov/TobaccoProducts/PublicHealthEducation/PublicEducationCampaigns/TheRealCostCampaign/ucm384054.htm